Product Information
ELLA 30 MG TABLET is a brand product labeled by HRA PHARMA AMERICA, INC., priced at $37.0980 per EA under NDC 73302045601. Its NADAC has been published 316 times since Sep 16, 2020.
FDA first approved this application on Aug 13, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
HRA PHARMA AMERICA, INC.NDC
73302045601
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ULIPRISTAL ACETATEApproval Type
New Drug (NDA)
FDA Application
NDA022474FDA Approved
8/13/2010
TE Code
AB
On Market Since
5/11/2020
Pharmacological Classes
Price Statistics
The NADAC for ELLA 30 MG TABLET has been published 316 times since Sep 16, 2020, and over the history we have for it it has risen 7.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $37.0980 per EA |
|---|---|
| All-time high | $37.3736 (Apr 13, 2022) |
| All-time low | $34.2750 (Feb 17, 2021) |
| 52-week high | $37.1107 |
| 52-week low | $37.0880 |
| Median price | $37.1920 |
| Average price | $36.8368 |
| Largest weekly change | +8.4% (Jul 7, 2021) |
| Weeks tracked | 316 |
| Tracking since | Sep 16, 2020 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ulipristal acetate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
HRA PHARMA AMERICA, INC. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ulipristal acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ELLA 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ELLA 30 MG TABLET, manufactured by HRA PHARMA AMERICA, INC., is $37.0980 per EA (NDC 73302045601), effective Sep 30, 2026.
How has the price of ELLA 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ELLA 30 MG TABLET has risen 7.8%. It has been tracked across 316 weekly CMS publications since Sep 16, 2020.
What are the highest and lowest recorded NADAC prices for ELLA 30 MG TABLET?
Since Sep 16, 2020, the NADAC for ELLA 30 MG TABLET has ranged from a low of $34.2750 (Feb 17, 2021) to a high of $37.3736 (Apr 13, 2022), with a median of $37.1920 per EA.
Are there cheaper alternatives to ELLA 30 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of ELLA 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ELLA 30 MG TABLET?
ELLA 30 MG TABLET (NDC 73302045601) is labeled by HRA PHARMA AMERICA, INC., and CMS classifies it as a brand product.